Terray, an AI-native, drug discovery and development company built at the intersection of AI and experimentation, will participate in investor conferences this September.

Morgan Stanley 24th Annual Global Healthcare Conference September 14th -16th

Jacob Berlin, CEO and co-founder and Eli Berlin, CFO/COO and co-founder will present to investors

Goldman Sachs Life Sciences Symposium - September 15th

Jacob Berlin, CEO and co-founder, will speak on the AI and Drug Discovery panel

Terray to Speak at September Investor Conferences